tickerreport.com
Neutralwww.tickerreport.com Β·
koru medical systems nasdaqkrmd releases earnings results hits estimates
ECON_DEBTWB_1104_MACROECONOMIC_VULNERABILITY_AND_DEBTWB_450_DEBTGENERAL_HEALTH
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedKORU Medical Systems (NASDAQ:KRMD) reported Q1 earnings with revenue beat and improved net loss, but no specific commercial mechanism or supply chain impact is identified. The company is a medical device firm; the earnings release is a routine financial update without material operational or market-wide implications.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Q1 2026 EPS ($0.02) met estimates
- Revenue $11.76M beat $11.28M forecast, up 22% YoY
- Net loss improved 33% to $0.8M
- Full-year revenue guidance $47.5M-$50M
- Stock traded at $4.01, market cap $186.91M